人结肠癌细胞KM12

细胞名称

人结肠癌细胞KM12

货物编码

BFN60808853

产品规格

T25培养瓶x1

1.5ml冻存管x2

细胞数量

1x10^6

1x10^6

保存温度

37℃

-198℃

运输方式

常温保温运输

干冰运输

安全等级

1

用途限制

仅供科研   2类

培养体系

90%DMEM+10%FBS+1%三抗

培养温度

37℃

二氧化碳浓度

5%

简介

人结肠癌细胞KM12取自女性供体。

注释

Part of: Cancer Cell Line Encyclopedia (CCLE) project.

Part of: COSMIC cell lines project.

Part of: JFCR39 cancer cell line panel.

Part of: MD Anderson Cell Lines Project.

Part of: NCI-60 cancer cell line panel.

Doubling time: 23 hours (PubMed=25984343); 23.7 hours (NCI-DTP).

Microsatellite instability: Instable (MSI-high) (PubMed=25926053; PubMed=28683746; PubMed=31068700; Sanger).

Omics: Array-based CGH.

Omics: CNV analysis.

Omics: Deep exome analysis.

Omics: Deep proteome analysis.

Omics: Deep quantitative phosphoproteome analysis.

Omics: Deep quantitative proteome analysis.

Omics: Deep RNAseq analysis.

Omics: DNA methylation analysis.

Omics: Fluorescence phenotype profiling.

Omics: lncRNA expression profiling.

Omics: Metabolome analysis.

Omics: N-glycan profiling.

Omics: Protein expression by reverse-phase protein arrays.

Omics: shRNA library screening.

Omics: SNP array analysis.

Omics: Transcriptome analysis.

Misspelling: KIM12; In GEO GSM846361.

基因突变

TPM3-NTRK1 gene fusion (PubMed=24962792; PubMed=25485619).

Homozygous for ACVR2A p.Lys437fs*5 (c.1310delA) (PubMed=12615714).

Heterozygous for APC p.Asn1819fs*7 (c.5454_5455insA) (PubMed=17088437).

BRAF p.Pro403fs (PubMed=28683746).

Heterozygous for BRCA2 p.Asn1784Hisfs*7 (c.5350_5351delAA) (PubMed=17088437).

Heterozygous for PTEN p.Gly129Ter (c.385G>T) and p.Lys267fs*9 (c.800delA) (PubMed=17088437; PubMed=28683746).

Heterozygous for TGFBR2 p.Lys128Serfs*35 (c.383delA) (PubMed=12615714).

Heterozygous for TP53 p.Arg72fs*51 (c.215delG) (PubMed=17088437; PubMed=28683746).

TP53 p.His179Arg (c.536A>G) (PubMed=15900046).

HLA信息

Class I

HLA-A        A*02

HLA-B        B*07:02:01

HLA-C        C*07:02:01

Class II

HLA-DP        DPB1*13:01

HLA-DQ        DQB1*03:02

HLA-DR        DRB1*04:01:01

STR信息

Amelogenin        X

CSF1PO        10,12

D3S1358        14

D5S818        10,17 (Cosmic-CLP)

10,18 (PubMed=19372543)

10 (PubMed=25877200; PubMed=25926053)

D7S820        8,9 (Cosmic-CLP)

8,8.3 (PubMed=19372543; PubMed=25877200; PubMed=25926053)

D8S1179        11,13

D13S317        12,15

D16S539        11

D18S51        13

D19S433        11,14

D21S11        27

FGA        20,22

Penta D        12

Penta E        14,18

TH01        9.3

TPOX        11,12

vWA        17 (PubMed=11416159)

17,19 (Cosmic-CLP; PubMed=19372543; PubMed=25877200; PubMed=25926053)

参考文献

PubMed=28683746; DOI=10.1186/s12943-017-0691-y

Berg K.C.G., Eide P.W., Eilertsen I.A., Johannessen B., Bruun J., Danielsen S.A., Bjornslett M., Meza-Zepeda L.A., Eknaes M., Lind G.E., Myklebost O., Skotheim R.I., Sveen A., Lothe R.A.

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.

Mol. Cancer 16:116-116(2017)

PubMed=28854368; DOI=10.1016/j.celrep.2017.08.010

Roumeliotis T.I., Williams S.P., Goncalves E., Alsinet C., Del Castillo Velasco-Herrera M., Aben N., Ghavidel F.Z., Michaut M., Schubert M., Price S., Wright J.C., Yu L., Yang M., Dienstmann R., Guinney J., Beltrao P., Brazma A., Pardo M., Stegle O., Adams D.J., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Choudhary J.S.

Genomic determinants of protein abundance variation in colorectal cancer cells.

Cell Rep. 20:2201-2214(2017)

PubMed=29444439; DOI=10.1016/j.celrep.2018.01.051

Yuan T.L., Amzallag A., Bagni R., Yi M., Afghani S., Burgan W., Fer N., Strathern L.A., Powell K., Smith B., Waters A.M., Drubin D., Thomson T., Liao R., Greninger P., Stein G.T., Murchie E., Cortez E., Egan R.K., Procter L., Bess M., Cheng K.T., Lee C.-S., Lee L.C., Fellmann C., Stephens R., Luo J., Lowe S.W., Benes C.H., McCormick F.

Differential effector engagement by oncogenic KRAS.

Cell Rep. 22:1889-1902(2018)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747

Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Cancer Res. 79:1263-1273(2019)

PubMed=31068700; DOI=10.1038/s41586-019-1186-3

Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Nature 569:503-508(2019)